Literature DB >> 30286924

Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis.

Anders H Tennøe1, Klaus Murbræch2, Johanna C Andreassen2, Håvard Fretheim1, Torhild Garen3, Einar Gude2, Arne Andreassen2, Svend Aakhus4, Øyvind Molberg1, Anna-Maria Hoffmann-Vold5.   

Abstract

BACKGROUND: Primary cardiac affection is common and is a major cause of death in systemic sclerosis (SSc), but there are knowledge gaps regarding the effect of cardiac dysfunction on mortality.
OBJECTIVES: The purpose of this study was to evaluate diastolic function in a large, unselected SSc cohort and assess the effect of diastolic dysfunction (DD) on mortality.
METHODS: SSc patients followed prospectively at the Oslo University Hospital from 2003 to 2016 with available echocardiographies and matched control subjects were included. DD was assessed by echocardiography according to the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines. Pulmonary hypertension (PH) was diagnosed by right heart catheterization. Vital status was available for all patients. Cox regression analyses with hazards ratios (HRs) were conducted.
RESULTS: Diastolic function was assessed in 275 SSc patients at baseline and in 186 patients at follow-up. At baseline, 46 of the 275 SSc patients (17%) were diagnosed with DD and 195 (71%) had normal diastolic function. After a median follow-up of 3.4 years (interquartile range: 1.6 to 6.2 years), the proportion of DD increased from 17% to 29%. During follow-up, 57% of patients with DD at baseline died, compared with 13% of patients with normal diastolic function. At baseline, 86 patients had performed right heart catheterization, and 43 were diagnosed with PH; of these 60% deceased. In multivariable Cox regression analyses, DD was a stronger predictor of death (HR: 3.7; 95% CI: 1.69 to 8.14; c-index 0.89) than PH (HR: 2.0; 95% CI: 1.1 to 3.9; c-index 0.84).
CONCLUSIONS: DD is frequent in SSc, and the presence of DD is associated with high mortality. DD exceeds PH with respect to predicting mortality.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  diastolic dysfunction; echocardiography; mortality; systemic sclerosis

Mesh:

Year:  2018        PMID: 30286924     DOI: 10.1016/j.jacc.2018.07.068

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; George Markousis-Mavrogenis; Loukia Koutsogeorgopoulou; Theodoros Dimitroulas; Vasiliki Vartela; Angelos Rigopoulos; Michel Noutsias; Genovefa Kolovou
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

2.  Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition.

Authors:  Cosimo Bruni; Maya H Buch; Daniel E Furst; Giacomo De Luca; Aleksandra Djokovic; Raluca B Dumitru; Alessandro Giollo; Marija Polovina; Alexia Steelandt; Kostantinos Bratis; Yossra Atef Suliman; Ivan Milinkovic; Anna Baritussio; Ghadeer Hasan; Anastasia Xintarakou; Yohei Isomura; George Markousis-Mavrogenis; Lorenzo Tofani; Sophie Mavrogeni; Luna Gargani; Alida Lp Caforio; Carsten Tschöpe; Arsen Ristic; Karin Klingel; Sven Plein; Elijah R Behr; Yannick Allanore; Masataka Kuwana; Christopher P Denton; Dinesh Khanna; Thomas Krieg; Renzo Marcolongo; Ilaria Galetti; Elisabetta Zanatta; Francesco Tona; Petar Seferovic; Marco Matucci-Cerinic
Journal:  J Scleroderma Relat Disord       Date:  2021-10-26

3.  Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement.

Authors:  Francesco Iannazzo; Chiara Pellicano; Amalia Colalillo; Cesarina Ramaccini; Antonella Romaniello; Antonietta Gigante; Edoardo Rosato
Journal:  Clin Exp Med       Date:  2022-07-25       Impact factor: 5.057

4.  Impact of previous cardiac function status assessed by echocardiography on the outcome of COVID-19.

Authors:  Irene Carrión; Carmen Olmos; María Luaces; Ana Isabel Cortés; Carlos Real; Alberto de Agustín; Roberta Bottino; Eduardo Pozo; Leopoldo Pérez de Isla; Fabián Islas
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

5.  Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality.

Authors:  Alicia M Hinze; Jamie Perin; Adrianne Woods; Laura K Hummers; Fredrick M Wigley; Monica Mukherjee; Ami A Shah
Journal:  Arthritis Rheumatol       Date:  2022-03-30       Impact factor: 15.483

6.  Left atrial stiffness is superior to volume and strain parameters in predicting elevated NT-proBNP levels in systemic sclerosis patients.

Authors:  Adél Porpáczy; Ágnes Nógrádi; Vivien Vértes; Margit Tőkés-Füzesi; László Czirják; András Komócsi; Réka Faludi
Journal:  Int J Cardiovasc Imaging       Date:  2019-05-15       Impact factor: 2.357

7.  Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study.

Authors:  Sheraz A Butt; Jørgen L Jeppesen; Christian Torp-Pedersen; Flora Sam; Gunnar H Gislason; Søren Jacobsen; Charlotte Andersson
Journal:  J Am Heart Assoc       Date:  2019-08-24       Impact factor: 5.501

8.  Acute Heart Failure in Scleroderma Renal Crisis: A Case Study for Review of Cardiac Disease in Systemic Sclerosis.

Authors:  Abhimanyu Amarnani; Perry Wengrofsky; Cindy L Tsui; Pramod Theetha Kariyanna; Naureen Kabani; Louis Salciccioli; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2019-11-05

Review 9.  Cardiac complications in systemic sclerosis: early diagnosis and treatment.

Authors:  Liu-Yan Nie; Xiao-Dong Wang; Ting Zhang; Jing Xue
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

10.  Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.

Authors:  Anthony Lindholm; Roger Hesselstrand; Göran Rådegran; Håkan Arheden; Ellen Ostenfeld
Journal:  Clin Physiol Funct Imaging       Date:  2019-01-16       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.